Capital Investment Counsel (Colorado)’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-68,204
Closed -$3.29M 140
2025
Q2
$3.29M Buy
68,204
+105
+0.2% +$5.37K 0.51% 72
2025
Q1
$3.78M Buy
68,099
+141
+0.2% +$7.63K 0.63% 70
2024
Q4
$3.28M Buy
67,958
+1,471
+2% +$74.8K 0.55% 69
2024
Q3
$3.83M Buy
66,487
+3,468
+6% +$187K 0.66% 63
2024
Q2
$3.06M Buy
63,019
+4,768
+8% +$230K 0.6% 65
2024
Q1
$2.83M Buy
58,251
+19,853
+52% +$969K 0.61% 62
2023
Q4
$1.91M Buy
+38,398
New +$1.88M 0.72% 63

Other funds holding SNY

Capital Investment Counsel (Colorado)'s SNY Position: Q3 2025 in Review

Capital Investment Counsel (Colorado) sold out of Sanofi (SNY) in Q3 2025, closing a stake of 68,204 shares — an estimated $3.29M sold.

Capital Investment Counsel (Colorado) first reported a position in SNY in Q4 2023 and held it in 7 quarters. The position peaked at $3.83M in Q3 2024. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Capital Investment Counsel (Colorado) reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Capital Investment Counsel (Colorado) sold 68,204 Sanofi shares in Q3 2025, an estimated $3.29M.
  • Capital Investment Counsel (Colorado) first reported a position in Sanofi in Q4 2023 and held it in 7 quarters.
  • Capital Investment Counsel (Colorado)'s Sanofi position peaked at $3.83M in Q3 2024.
  • 712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Capital Investment Counsel (Colorado)'s 13F filing for Q3 2025, filed 6 Nov 2025.